Xuan Wang

2PUBLICATIONS
23CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Oct 24, 2026
LM103, an autologous tumor-infiltrating lymphocyte monotherapy, in patients with advanced melanoma resistant to standard therapy.

|Feb 06, 2025
Oncolytic virus OH2 extends survival in patients with PD-1 pretreated melanoma: phase Ia/Ib trial results and biomarker insights.

Xuan Wang, Hui Tian, Zhihong Chi

Pageof 1

Frequent Collaborators

2 joint publications

Lu Si

2 joint publications

Bin Lian

2 joint publications

Li Zhou

2 joint publications

Chuanliang Cui